Equity · Healthcare
AORT
NYSEArtivion (AORT)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for AORT to draw a line in its place.
- Market cap
- 986.0M USD
- Revenue, year to Dec 2025
- 441.3M USD
- EPS, diluted, year to Dec 2025
- 0.21 USD
- 52-week range
- 20 USD – 48 USD
- Avg volume
- 42.2K
as of Nov 6, 2026
Have Artivion (AORT) insiders bought or sold shares recently?
AORT has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 10 September 2026.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 10 Sep 2026 | GREEN ANDREW MSVP, Regulatory and Quality | Sell | 11,480 | 287K USD |
| 03 Sep 2026 | GREEN ANDREW MSVP, Regulatory and Quality | Sell | 1,493 | 39K USD |
| 02 Sep 2026 | GREEN ANDREW MSVP, Regulatory and Quality | Sell | 6,510 | 177K USD |
| 19 Aug 2026 | Mackin James PPresident & CEO | Sell | 70,000 | 2.0M USD |
| 14 Aug 2026 | Berry Lance AEVP, COO, CFO & Treasurer | Sell | 715 | 20K USD |
| 14 Aug 2026 | GREEN ANDREW MSVP, Regulatory and Quality | Sell | 616 | 18K USD |
| 12 Aug 2026 | Holloway Jean FSVP, General Counsel | Sell | 977 | 28K USD |
| 11 Jun 2026 | GREEN ANDREW MSVP, Regulatory and Quality | Sell | 44,001 | 911K USD |
| 04 Mar 2026 | Holloway Jean FSVP, General Counsel | Sell | 8,962 | 341K USD |
| 03 Mar 2026 | Mackin James PPresident & CEO | Sell | 17,887 | 676K USD |
| 03 Mar 2026 | Berry Lance AEVP, COO, CFO & Treasurer | Sell | 6,316 | 239K USD |
| 03 Mar 2026 | Davis John EChief Commercial Officer | Sell | 4,573 | 173K USD |
| Sold | 57 open-market sales | 539,267 | $20.73M |
Showing the 12 most recent of 57 open-market trades in this window. The figures above count all of them.
32 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 11 Jun 2026 | GREEN ANDREW MSVP, Regulatory and Quality | Option exercise | 44,001 | 589K USD |
| 02 Jun 2026 | SEMEDO ANTHONY B.Director | Other | 12,650 | |
| 18 May 2026 | ACKERMAN THOMAS FDirector | Award | 7,576 | |
| 18 May 2026 | BEVEVINO DANIEL JDirector | Award | 7,576 | |
| 18 May 2026 | Bullock JamesDirector | Award | 7,576 | |
| 18 May 2026 | Burbank Jeffrey HDirector | Award | 7,576 | |
| 18 May 2026 | Hoff Elizabeth ADirector | Award | 7,576 | |
| 18 May 2026 | Salveson Jon WDirector | Award | 7,576 | |
| 18 May 2026 | SEMEDO ANTHONY B.Director | Award | 7,576 | |
| 18 May 2026 | Borgstrom Marna PDirector | Award | 7,576 | |
| 14 May 2026 | Borgstrom Marna PDirector | Award | 7,850 | |
| 02 Mar 2026 | Mackin James PPresident & CEO | Award | 116,948 |
Showing the 12 most recent of 32 compensation filings in this window. The figures above count all of them.
Which funds hold Artivion (AORT)?
6 of the 45 institutional funds we track reported a Artivion position for the quarter ended 30 Jun 2026 — a combined 47.6M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Citadel Advisors | Added | 827,594 | 18.6M USD | +1,067.8% |
| D. E. Shaw & Co. | Added | 438,216 | 9.8M USD | +6,614.9% |
| Two Sigma Investments | Trimmed | 387,279 | 8.7M USD | −46.6% |
| Balyasny Asset Management | Added | 382,051 | 8.6M USD | +1,192.7% |
| Renaissance Technologies | New position | 67,827 | 1.5M USD | |
| AQR Capital Management | Held (±25%) | 14,383 | 323K USD | −21.4% |
| Man Group | Exited | |||
| Marshall Wace | Exited |
Have members of Congress traded Artivion (AORT)?
The most recent congressional trade disclosed in Artivion is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 20 Aug 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 20 Aug 2026 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | 1K USD–15K USD | 21 days |
| 09 Oct 2025 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Sale | 1K USD–15K USD | 40 days |
| 14 Jul 2023 | Josh Gottheimerhouse · Democrat–NJ | Purchase | 1K USD–15K USD | 38 days |
| 13 Jun 2023 | Josh Gottheimerhouse · Democrat–NJ | Sale | 1K USD–15K USD | 28 days |
What has been filed or recorded for Artivion (AORT)?
The filings we hold for Artivion, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.16 USD | |
| 30 Sep 2026 | Financials | Total assets | 1.0B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 446.4M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.28 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.03 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 0.21 USD | |
| 31 Dec 2025 | Financials | Revenue | 441.3M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 9.8M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 0.21 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.13 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.03 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.01 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.32 USD |
Artivion (AORT): frequently asked questions
What is Artivion’s market cap?
Artivion is worth 986.0M USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Artivion’s revenue?
Artivion reported revenue of 441.3M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Artivion insiders bought or sold shares recently?
No Artivion insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 10 Sep 2026 (SEC Form 4). See Insiders
Which funds own Artivion?
6 of the 45 funds we track reported a Artivion position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, D. E. Shaw & Co. and Two Sigma Investments. See Funds
Have members of Congress traded Artivion?
Yes. 4 trades in Artivion appear in the congressional disclosures we hold; the latest is a purchase by Gilbert Ray Cisneros, Jr. (House, CA) dated 20 Aug 2026, filed 10 Sep 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Artivion last report earnings?
Artivion last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.16 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings